Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).
about
Obstructive sleep apnea syndrome and fatty liver: association or causal link?Managing dyslipidemia in HIV/AIDS patients: challenges and solutionsLongitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice.Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathwayDietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signalingXyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models.Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance.Distinct effects of calorie restriction and resveratrol on diet-induced obesity and Fatty liver formationTranscriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model.Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.Emodin, a Naturally Occurring Anthraquinone Derivative, Ameliorates Dyslipidemia by Activating AMP-Activated Protein Kinase in High-Fat-Diet-Fed RatsDietary fiber prevents obesity-related liver lipotoxicity by modulating sterol-regulatory element binding protein pathway in C57BL/6J mice fed a high-fat/cholesterol diet(-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed MiceDietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats.The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse modelSirt1 protects against high-fat diet-induced metabolic damage.Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathwayHepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.Isoquercitrin activates the AMP-activated protein kinase (AMPK) signal pathway in rat H4IIE cells.Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions.The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome.OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease.Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice.Anti-Obesity Effect of the Above-Ground Part of Valeriana dageletiana Nakai ex F. Maek Extract in High-Fat Diet-Induced Obese C57BL/6N Mice.Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.Detection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics.Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress.The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.Inhibitory Effects of Chung Hun Wha Dam Tang (CHWDT) on High-Fat Diet-Induced Obesity via AMP-Activated Protein Kinase Activation.Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male MiceComparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.Amelioration of free fatty acid-induced fatty liver by quercetin-3-O-β-D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element-binding protein-1c signaling.
P2860
Q24612841-28A67BAE-F84B-4C2C-93A7-43CC47F21A0BQ28084941-0C845DBB-55C5-4E64-869F-34D3E7AABD41Q30586373-157567FC-20B3-44FE-8952-C7B3C566E82EQ33612522-DA765752-E1FE-43BB-8A0A-0ACFD33351B4Q33758991-73BEB323-0178-4497-BFC2-53F2141C9644Q33833358-8D7209ED-0A84-4F3B-A5CF-48B0DD33E642Q34137610-6B39168C-AD27-4FED-916A-3F605125AE27Q35250903-B8009DDD-5A84-4F41-BCDA-A0F1E479D3B1Q35745015-52A26609-D582-4599-8ACF-73B30FBE07CDQ35965770-654133B4-86E3-45A1-A47E-29EE9181A627Q35979123-E7071BF5-8F3B-4962-94FC-44580EEAA7DFQ36221625-F1EEAE5D-C41E-4BFF-A2E6-D71FE8BF7A70Q36247485-BAD11706-B72B-4436-88B6-F51060085FC0Q36335120-FE327E9B-7C03-42E2-A28C-48198DB96F0CQ36470460-C5F4C4DC-4AA3-444B-9036-C42E70A566E3Q36479005-76238FC2-BD2E-4B26-8E62-A688A68ADB00Q36642388-131FE151-3474-49BE-BCCB-CF26F5E68C71Q36775324-C9CFED10-13F5-4CB9-B860-C56C9AC0FE5FQ37071477-389DE56A-7BDB-4F08-8C8E-EEF19EE82B1CQ37130242-196F0F3B-C270-4388-A662-ED071B811624Q37155389-94C3A521-B161-4760-86D0-DBE959E2BFB8Q37555560-221213CE-F8D2-4816-87BA-3E8CBF8EB39DQ37571401-A1D20AB3-6F63-4659-ACF6-2DDF87DFCB2FQ37951499-D6204046-14E4-4135-9F7D-65D1D0CCE462Q37973510-6A3F9BE1-105E-4E34-ABE6-9B3AA84D9F66Q38024436-486C5FB0-78E2-4C8E-84E9-E14750C523A7Q38200139-4CD5BD69-4DFB-456F-ABD7-744525843907Q38421096-6F53D381-FDFD-4E57-8743-93DA024188B6Q38687860-8B2439EC-142E-4B58-8578-738915CDE1F7Q38696913-B0C2FB59-8FAC-41DB-847C-91EC558027EBQ38939502-47E57E10-A464-4AFB-9C18-CBC3E4B7609EQ39414910-7A79115F-EA17-40EE-B324-9E302D192DDDQ39531917-34DBEE00-D7C0-451A-AFB4-C64DAF04C1E8Q39647789-CE188B88-0C4B-4C87-94B1-5F5CA76C9B3FQ39896001-259AD3AB-5278-4458-B8F4-A166412398E6Q41195887-69D8E49A-AE25-4CE5-BB7D-3CC9219E061DQ41899959-3379D709-146A-4B79-B5AF-94075081125AQ42107886-D4CC6A13-61FF-4176-8E18-8058C51EFAD8Q42607892-AFF20C83-B765-460E-8C6C-63F0F59BF0D9Q42701165-4C94AD22-F3BD-4753-AB0E-AEA1B17017AA
P2860
Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Modulation of sterol regulator ...... c fatty liver disease (NAFLD).
@en
type
label
Modulation of sterol regulator ...... c fatty liver disease (NAFLD).
@en
prefLabel
Modulation of sterol regulator ...... c fatty liver disease (NAFLD).
@en
P1433
P1476
Modulation of sterol regulator ...... ic fatty liver disease (NAFLD)
@en
P2093
Mohamed H Ahmed
P304
P356
10.1016/J.DRUDIS.2007.07.009
P577
2007-08-27T00:00:00Z